Ginger Graham is listed as a director on 7 SEC Form D filings by 1 issuer between Aug 2012 and Nov 2018: Elcelyx Therapeutics, Inc. (San Diego, CA — biotechnology — 2012–2018; $24.7M reported sold to 13 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alain D. Baron (7 shared filings), Jim Glasheen (7 shared filings), Mark Fineman (7 shared filings), Martin R. Brown (6 shared filings), Brook Byers (5 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ginger. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for Ginger Graham and found 8 differences: 22% of the money raised went to insiders; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.